Reproducible immortalization of erythroblasts from multiple stem cell sources provides approach for sustainable RBC therapeutics. (2021)
Attributed to:
Developing human model cellular systems for studying Red Blood Cell diseases and as screening platforms
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.omtm.2021.06.002
PubMed Identifier: 34485592
Publication URI: http://europepmc.org/abstract/MED/34485592
Type: Journal Article/Review
Volume: 22
Parent Publication: Molecular therapy. Methods & clinical development
ISSN: 2329-0501